-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Review: Clinical Trail Outcomes: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation